Oscar Health, Inc. (OSCR) shares plummeted by 5.08% on Thursday morning during the trading session, underperforming the broader market.
Bank of America Securities analyst Adam Ron reiterated a "Sell" rating on Oscar Health and set a relatively low price target, reflecting concerns over the company's recent performance and outlook.
The analyst's downgrade was driven by Oscar Health's revenue miss and potential risks surrounding its enrollment numbers. The company's ability to attract and retain customers is crucial for its growth and profitability, and any challenges in this area could weigh heavily on its stock.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。